Article Dans Une Revue Molecular Informatics Année : 2023

Predicting the duration of action of β2‐adrenergic receptor agonists: Ligand and structure‐based approaches

Luca Chiesa
  • Fonction : Auteur
  • PersonId : 1379372
Emilie Sick
  • Fonction : Auteur
  • PersonId : 1112665

Résumé

Agonists of the β2 adrenergic receptor (ADRB2) are an important class of medications used for the treatment of respiratory diseases. They can be classified as short acting (SABA) or long acting (LABA), with each class playing a different role in patient management. In this work we explored both ligand-based and structure-based high-throughput approaches to classify β2-agonists based on their duration of action. A completely in-silico prediction pipeline using an AlphaFold generated structure was used for structure-based modelling. Our analysis identified the ligands’ 3D structure and lipophilicity as the most relevant features for the prediction of the duration of action. Interaction-based methods were also able to select ligands with the desired duration of action, incorporating the bias directly in the structure-based drug discovery pipeline without the need for further processing.
Fichier principal
Vignette du fichier
islandora_170785.pdf (3) Télécharger le fichier
Origine Publication financée par une institution

Dates et versions

hal-04563642 , version 1 (29-04-2024)

Identifiants

Citer

Luca Chiesa, Emilie Sick, Esther Kellenberger. Predicting the duration of action of β2‐adrenergic receptor agonists: Ligand and structure‐based approaches. Molecular Informatics, 2023, 42 (12), pp.e202300141. ⟨10.1002/minf.202300141⟩. ⟨hal-04563642⟩
18 Consultations
13 Téléchargements

Altmetric

Partager

More